Site Map


Public Lecture "Designing and developing the world's first anti-influenza drug"


On May 14, College of Science will hold a public lecture, "Designing and developing the world's first anti-influenza drug". The lecturer will be Professor Mark von Itzstein.

Time and Date 18:00-19:00,Thursday, May 14, 2015
Place Ikebukuro Campus Tachikawa Memorial Hall, Third Floor, Multipurpose Hall
Lecturer Professor Mark von Itzstein (Griffith University , Australia)
Professor Mark von Itzstein is a director of Griffith University’s Institute for Glycomics, located in the Gold Coast, Australia. Based on the research on the synthesis of sialic acid derivatives, he succeeded in designing and developing the world's first anti-influenza drug Relenza® (Zanamivir). By using techniques based on glycochemistry and glycobiology, he is actively engaged in development of novel drugs against viruses including parainfluenza viruses, which have been untreated with existing clinical therapeutic agents.
Open to Student, faculty members, alumni, public
*Registration not required, admission free
Language English

Go to the news list

Monthly list

Yearly list

Return to Top of Page

Ikebukuro Campus(Public relations)
3-34-1 Nishi-Ikebukuro,Toshima-ku,
Tokyo Japan 171-8501
Niiza Campus(Niiza campus service division)
1-2-26 Kitano,Niiza-shi,
Saitama Japan 352-8558
Copyright © Rikkyo University. All Rights Reserved.